Latest News

FDA black and white logo | Credit: US Food and Drug Administration
Nebokitug (CM-101) Gets FDA Runway for PSC Approval

February 19th 2025

Chemomab completed an end-of-phase 2 meeting with the FDA and has aligned on the design of a phase 3 registration study for nebokitug (CM-101) in PSC.

Thomas Vanwolleghem, MD, PhD | Credit: Thomas Vanwolleghem on LinkedIn
HDV RNA Positivity Linked to Greater Risk of Severe Liver-Related Outcomes

February 19th 2025

Liver | Credit: Adobe Stock
Namodenoson Improves Decompensated Liver Cirrhosis Episodes

February 18th 2025

Hee-Soon Juon, MSN, PhD | Credit: Thomas Jefferson University
HBV Knowledge, Stigma Impact Medication Adherence in High-Risk Patients

February 18th 2025

Jeffrey Schwimmer, MD | Credit: UC San Diego
Up to 11% of US Adolescents Have Suspected MASLD, Study Finds

February 17th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.